463 related articles for article (PubMed ID: 9865668)
1. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk.
Dickerman RD; McConathy WJ; Zachariah NY
J Cardiovasc Risk; 1997; 4(5-6):363-6. PubMed ID: 9865668
[TBL] [Abstract][Full Text] [Related]
2. Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study.
Agledahl I; Skjaerpe PA; Hansen JB; Svartberg J
Nutr Metab Cardiovasc Dis; 2008 May; 18(4):256-62. PubMed ID: 17560771
[TBL] [Abstract][Full Text] [Related]
3. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
4. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span.
Bell RJ; Davison SL; Papalia MA; McKenzie DP; Davis SR
Menopause; 2007; 14(4):630-8. PubMed ID: 17224854
[TBL] [Abstract][Full Text] [Related]
5. The association of androgenic sex steroids with serum lipid levels in postmenopausal women.
Noyan V; Yucel A; Sagsoz N
Acta Obstet Gynecol Scand; 2004 May; 83(5):487-90. PubMed ID: 15059164
[TBL] [Abstract][Full Text] [Related]
6. Serum sex hormones in premenopausal women with coronary heart disease.
Mohamad MJ; Karayyem M; Mohammad MA; Al-Alami J; Al-Hader A
Neuro Endocrinol Lett; 2006 Dec; 27(6):758-62. PubMed ID: 17186999
[TBL] [Abstract][Full Text] [Related]
7. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
[TBL] [Abstract][Full Text] [Related]
8. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
Langsted A; Freiberg JJ; Nordestgaard BG
Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
[TBL] [Abstract][Full Text] [Related]
9. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
Mendoza SG; Zerpa A; Carrasco H; Colmenares O; Rangel A; Gartside PS; Kashyap ML
Artery; 1983; 12(1):1-23. PubMed ID: 6431945
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
Stampfer MJ; Sacks FM; Salvini S; Willett WC; Hennekens CH
N Engl J Med; 1991 Aug; 325(6):373-81. PubMed ID: 2062328
[TBL] [Abstract][Full Text] [Related]
11. High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use.
Hurley BF; Seals DR; Hagberg JM; Goldberg AC; Ostrove SM; Holloszy JO; Wiest WG; Goldberg AP
JAMA; 1984 Jul; 252(4):507-13. PubMed ID: 6737643
[TBL] [Abstract][Full Text] [Related]
12. An assessment of correlations between endogenous sex hormone levels and the extensiveness of coronary heart disease and the ejection fraction of the left ventricle in males.
Dobrzycki S; Serwatka W; Nadlewski S; Korecki J; Jackowski R; Paruk J; Ladny JR; Hirnle T
J Med Invest; 2003 Aug; 50(3-4):162-9. PubMed ID: 13678385
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
Undén AL; Elofsson S; Brismar K
Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
[TBL] [Abstract][Full Text] [Related]
14. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
16. Diet and waist-to-hip ratio: important predictors of lipoprotein levels in sedentary and active young men with no evidence of cardiovascular disease.
Mansfield E; McPherson R; Koski KG
J Am Diet Assoc; 1999 Nov; 99(11):1373-9. PubMed ID: 10570674
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
[TBL] [Abstract][Full Text] [Related]
19. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
Mesch VR; Siseles NO; Maidana PN; Boero LE; Sayegh F; Prada M; Royer M; Schreier L; Benencia HJ; Berg GA
Climacteric; 2008; 11(6):509-17. PubMed ID: 18991078
[TBL] [Abstract][Full Text] [Related]
20. The association of apolipoprotein B and low density lipoprotein with cardiovascular risk factors in the Thai population.
Krittayaphong R; Chotinaiwatarakul C; Kangkagate C; Bhuripanyo K; Mahanonda N
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S1-7. PubMed ID: 17722296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
